Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1027 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 |
filingDate |
2004-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df718b1fa60c08eee03f98a875b78c3c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2655400e41687e8ffe0aa1a26b3849f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e2b1aae3dd6a5d8c8c32f83642fadac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25935c610a3c0c769e6680483531dc6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40ec477961883607940f36479302850b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39aa857d04a630983deddf932e604be6 |
publicationDate |
2005-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2005147616-A1 |
titleOfInvention |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
abstract |
The present invention encompasses novel antibodies and fragments thereof which immunospecifically bind to one or more RSV antigens and compositions comprising said antibodies and antibody fragments. The present invention encompasses methods preventing respiratory syncytial virus (RSV) infection in a human, comprising administering to said human a prophylactically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention also encompasses methods for treating or ameliorating symptoms associated with a RSV infection in a human, comprising administering to said human a therapeutically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention further encompasses compositions comprising antibodies or fragments thereof that immunospecifically bind to a RSV antigen, and methods using said compositions for detection or diagnosis a RSV infection |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006198840-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8012476-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007048332-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7670600-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7294336-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7700735-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004018200-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007196916-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002098189-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7229619-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7847082-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7179900-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005196749-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7553489-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010189718-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006115485-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7425618-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010028948-A1 |
priorityDate |
2000-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |